Copper treatment could help the brain clear harmful proteins linked to alzheimer’s

Date:

Share this article:

Del denne artikel:

A new study is investigating a treatment that may help the brain remove substances linked to Alzheimer's disease.

Alzheimer's disease is the most common form of dementia and affects millions of people worldwide.

As a result, researchers are constantly searching for new ways to slow the progression of the disease.

A research team from Monash University in Australia has now examined a potential new treatment that targets the brain's own waste-clearing mechanisms, SciTechDaily reports.

The brain's waste disposal system

The researchers focused on the blood-brain barrier, which acts as a filter between the brain and the bloodstream.

Also read: Nutrition expert gave up complicated diets – now she swears by one simple rule

This barrier contains specialized transport proteins that help remove waste products from the brain.

In Alzheimer's disease, these proteins become less effective.

This can lead to the accumulation of beta-amyloid, a protein associated with the disease.

Promising results

The study, published in the journal ACS Chemical Neuroscience, examined a copper-based compound called Cu(ATSM).

Also read: The daily routines experts say can slow down the aging process

In laboratory experiments, the researchers found that the treatment increased the levels of transport proteins that help remove waste products from the brain.

At the same time, lower levels of beta-amyloid were observed, and the test animals performed better in memory and spatial orientation tests.

According to the researchers, Cu(ATSM) appears to restore an important part of the brain's waste disposal system, allowing harmful proteins to be removed more efficiently.

Since the compound has already undergone safety testing in connection with diseases such as Parkinson's disease and ALS, the researchers believe that the next step could be human trials.

Also read: Scientists find remarkable connection between GLP-1 drugs and cancer

Also read: What Happens When You Eat a Banana Before Sleep?

This article is made and published by Ida-Marie Palm Varbæk, who may have used AI in the preparation.

Other articles

Millions may lose GLP-1 drug coverage as employers and insurers cut benefits

The bill for weight-loss drugs like Wegovy is landing on patients as major insurers pull back.

How eating meat every day may affect your heart

Meat is a common source of protein, iron, and vitamin B12, but not all types of meat have...

Nearly 1 in 6 children on weight loss drugs developed a nutritional deficiency within a year

A new US study of more than 2,000 children on GLP-1 medications found that 16.8 percent developed a nutritional deficiency within twelve months, and vitamin D led the list.

7 supplements to avoid if you take an SSRI

About 1 in 9 US adults now takes a prescription antidepressant, and pairing one with the wrong supplement can push brain serotonin to dangerous levels.

Millions may lose GLP-1 drug coverage as employers and insurers cut benefits

The bill for weight-loss drugs like Wegovy is landing on patients as major insurers pull back.

How eating meat every day may affect your heart

Meat is a common source of protein, iron, and vitamin B12, but not all types of meat have...

Nearly 1 in 6 children on weight loss drugs developed a nutritional deficiency within a year

A new US study of more than 2,000 children on GLP-1 medications found that 16.8 percent developed a nutritional deficiency within twelve months, and vitamin D led the list.